TGTX TG Therapeutics, Inc.
$59.83
TG Therapeutics, Inc. (TGTX) Earnings News
Earnings press releases, previews and reviews for TG Therapeutics, Inc. (TGTX), newest first. Our most recent is review: TG Therapeutics Misses the Whisper but Raises Guidance a Fourth Time, Leaving More of the Year Riding on Q4.
Monday
November 9, 2026
10:49 AM ET
TG Therapeutics Misses the Whisper but Raises Guidance a Fourth Time, Leaving More of the Year Riding on Q4
Earnings Whispers · Review
Monday
November 9, 2026
7:00 AM ET
TG Therapeutics Reports Third Quarter 2026 Financial Results and Raises Full-Year Revenue Guidance
Monday
November 2, 2026
4:15 PM ET
TG Therapeutics Tests Briumvi Momentum Against Seasonal Lull as Stock Nears Breakout
Earnings Whispers · Preview
Monday
November 2, 2026
7:30 AM ET
TG Therapeutics to Host Conference Call on Third Quarter 2026 Financial Results and Business Update
Monday
August 3, 2026
7:00 AM ET
TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance
Wednesday
July 29, 2026
7:30 AM ET
TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update